Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Information Technology · ·
$346.63
▼ $1.18 (-0.3%)
Market data updated: 09/20 09:23 AM
Fundamentals updated: 09/19/2026
News analyzed: 09/20/2026
Market Cap
$16.40B
Day Range
$342.07 - $349.99
52-Week Range
$199.05 - $386.23
Beta
—
Next Earnings
03.11.2026
Support
$250.32
Resistance
$386.23
ZBRA is a stock from the Technology sector — Software, hardware, chip, and computing-services companies — revenue tied to the pace of innovation and upgrade cycles.
+7.4% (1Y)
Strengths: 6/31 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟡 Mixed
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Price vs. SMA 50
Price is above the 50-day average
Technical
Biggest negative driver
DCF Fair Value
Estimated fair value: $188.14 vs. price $346.63 (-45.7%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
52
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
34
Quality
42
Value
33
Momentum
59
Risk
34
Sentiment
100
Fundamental
55
Institutional
0
Stocks with a similar DNA right now
SCANNING ZBRA...
Recent media coverage of Zebra Technologies (ZBRA) has centered on its stock performance, recent earnings reports, and strategic initiatives. The company’s shares have faced a 4.9% decline since its last earnings report, prompting investor analysis. However, positive trends include its inclusion on Zacks’ *Strong Buy* list, praise for its 2026 sales outlook, and the acquisition of Elo—highlighting growth in digitization and automation. Additionally, Zebra announced participation in Citi’s tech conference and a healthcare deployment case at University Health, showcasing its solutions in workflow modernization.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Zebra Technologies. News trend score: 100. Reason: 13 of the last 20 articles are positive, versus 2 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
48
🎯 Conviction (vs. Emotion)
36
Psychology
58
Fundamentals
55
Technical
59
Valuation
33
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price rise has far outpaced the actual improvement in fundamental data.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
+47%
Market Narrative
78
Fundamental Reality
36
Narrative Gap
+42
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
ZBRA’s market behavior suggests a disconnect between valuation extremes and technical momentum, with euphoria dominating despite weak momentum. The narrative gap (68 vs. 36) implies investors overestimate fundamentals, while overconfidence may stem from ignoring momentum-fair-value divergence. Key question: Is the premium (+86% over DCF) justified by future growth, or will reality correct the overvaluation? The lack of panic or FOMO signals suggests complacency, not urgency, in current positioning.
Updated: 09/08/2026, 04:19 PM
What could change this?
👥 What the crowd believes
"ZBRA and MNTK have been added to the Zacks Rank #1 (Strong Buy) List"
"ZBRA is gaining from ... Elo acquisition benefits"
"University Health has deployed Zebra mobile computers ... reducing callback wait times"
"Zebra Technologies wins three Red Dot Design Awards for Devices"
📈 12D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 72/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 5/100
🗣️ Why do they disagree?
The stark divide in verdicts for ZBRA reflects deep contrasts in methodology priorities. Samuel Armstrong Nelson’s high score suggests he’d see a cyclical opportunity near an oversold trough, aligning with his technical and momentum-driven approach. Meanwhile, the overwhelming majority—including Graham, Fisher, and Marks—flag severe red flags, from valuation gaps to speculative risk, prioritizing defensive metrics, quality, or structural stability. Even the efficient-market camp justifies a deviation, hinting at a niche case, while the lowest scorers (Graham, Veblen) dismiss it outright as either statistically unsafe or growth-chasing without substance. The debate hinges on whether ZBRA’s volatility or cyclicality justifies a contrarian bet (Nelson, Malkiel) or if its risks outweigh any potential (Graham, Fisher).
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 72
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟢 69
A real, well-supported case — deviating from a broad index may be justified here
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 43
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 39
Looks late-cycle — the position Marks would treat with extra caution
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 37
Pattern consistent with a crowd delusion Mackay would flag
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 37
Doesn't show the stability Smith's long-term case requires
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 33
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 27
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 25
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 25
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 21
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🔴 20
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 19
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 18
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 8
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 5
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🟡 Indicators are mixed — no clear bias (5 bullish · 4 bearish · 2 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
48.1%
Operating Margin
13.0%
Net Margin
7.8%
EBITDA Margin
16.4%
ROE
11.7%
ROA
4.9%
ROIC
—
EPS
$8.24
Cash
$125.00M
Total Debt
$2.50B
Current Ratio
0.97
Debt/Equity
0.70
How is Fair Value calculated? →
Current Price
$346.63
Estimated Fair Value (DCF)
$188.14
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-45.7%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
-1.2%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -1.2% | $820.71M | $752.95M |
| 2 | -0.3% | $818.22M | $688.68M |
| 3 | 0.6% | $823.39M | $635.81M |
| 4 | 1.6% | $836.28M | $592.44M |
| 5 | 2.5% | $857.18M | $557.11M |
Base FCF (last actual year)
$831.00M
Terminal Value
$13.52B
Present Value of Terminal Value
$8.79B
Enterprise Value
$12.01B
Net Debt
$2.38B
Equity Value
$9.64B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$70.06
Tangible Book Value per Share (Tangible NAV)
-$38.04
Sentiment based on basic keywords (not AI) — 13 positive, 5 neutral, 2 negative out of the last 20 articles.
Yahoo · 18.9.2026
Yahoo · 17.9.2026
Yahoo · 16.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Benzinga · 15.9.2026
Benzinga · 15.9.2026
Yahoo · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 9.9.2026
SeekingAlpha · 9.9.2026
SeekingAlpha · 3.9.2026
Zacks · 3.9.2026
Yahoo · 3.9.2026
Zacks · 3.9.2026
Yahoo · 3.9.2026
Yahoo · 2.9.2026
Zebra Technologies (ZBRA) currently has a StockIQ AI score of 52/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
ZBRA currently scores 52/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, ZBRA's estimated fair value is $188.14, which is 45.7% below the current price of $346.63. This is one valuation model among several signals in the fair-value category, not a price target.
ZBRA's technical score is 59/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Price is above the 50-day average; Price is above the 200-day average; RSI 50.3 — healthy positive momentum.
Based on the real signals StockIQ computed: Estimated fair value: $188.14 vs. price $346.63 (-45.7%); Operating margin is eroding over time; Current ratio: 0.97.
StockIQ has no recorded dividend payment history for ZBRA.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 6 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Connly Linda | Open Market Sale | 10.8.2026 | 500 | -500 | $377.68 |
| Connly Linda | Open Market Sale | 10.8.2026 | 3,708 | -500 | $377.68 |
| Cho Michael | Open Market Sale | 7.8.2026 | 3,500 | -3,500 | $375.20 |
| Cho Michael | Open Market Sale | 7.8.2026 | 5,170 | -3,500 | $375.20 |
| Luff Loizides Melissa | Tax Withholding in Shares | 3.8.2026 | 46 | -46 | $291.64 |
| Luff Loizides Melissa | Tax Withholding in Shares | 3.8.2026 | 3,656 | -46 | $291.64 |
| Luff Loizides Melissa | Open Market Sale | 26.5.2026 | 500 | -500 | $253.95 |
| Luff Loizides Melissa | Open Market Sale | 26.5.2026 | 3,702 | -500 | $253.95 |
| Connors Nelda J | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| Miller Kenneth Bradley | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| SMITH MICHAEL A | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| MANIRE ROSS W | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| Modruson Frank Blaise | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| Connly Linda | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| GUSTAFSSON ANDERS | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| ROBERTS JANICE M | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| MCDOWELL MARY T | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| Dhanasekaran Satish | Grant/Award from Employer | 19.5.2026 | 951 | +951 | $247.15 |
| MCDOWELL MARY T | Grant/Award from Employer | 19.5.2026 | 1,520 | +951 | $247.15 |
| GUSTAFSSON ANDERS | Grant/Award from Employer | 19.5.2026 | 228,443 | +951 | $247.15 |
| MANIRE ROSS W | Grant/Award from Employer | 19.5.2026 | 16,759 | +951 | $247.15 |
| ROBERTS JANICE M | Grant/Award from Employer | 19.5.2026 | 7,134 | +951 | $247.15 |
| SMITH MICHAEL A | Grant/Award from Employer | 19.5.2026 | 11,646 | +951 | $247.15 |
| Connors Nelda J | Grant/Award from Employer | 19.5.2026 | 4,128 | +951 | $247.15 |
| Modruson Frank Blaise | Grant/Award from Employer | 19.5.2026 | 16,311 | +951 | $247.15 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,865,241 shares short as of 2026-08-31 · vs. 2,673,844 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
59.4% of trading volume this week was short selling, vs. 54.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology